Loss of AP-2 Results in Up-regulation ofMCAM/MUC18 and an Increase in Tumor Growth and Metastasis of Human Melanoma Cells
Open Access
- 1 June 1998
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 273 (26) , 16501-16508
- https://doi.org/10.1074/jbc.273.26.16501
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expressionNature Genetics, 1997
- Bcl-2 expression in malignant melanoma and its prognostic significanceEuropean Journal of Surgical Oncology, 1996
- Wild-Type p53 Regulates Its Own Transcription in a Cell-Type Specific MannerDNA and Cell Biology, 1995
- Linkage analysis in familial melanoma kindreds to markers on chromosome 6pInternational Journal of Cancer, 1994
- N-ras oncogene causes AP-2 transcriptional self-interference, which leads to transformation.Genes & Development, 1994
- Expression of gp 185HER‐2 in human cutaneous melanoma: Implications for experimental immunotherapeuticsInternational Journal of Cancer, 1994
- Direct correlation between MUC18 expression and metastatic potential of human melanoma cellsMelanoma Research, 1993
- The putative melanoma tumor-suppressor gene on human chromosome 6qPathology, 1992
- Localization of the gene for the DNA-binding protein AP-2 to human chromosome 6p22.3-pterGenomics, 1991
- Characterization of a Dimerization Motif in AP-2 and Its Function in Heterologous DNA-Binding ProteinsScience, 1991